» Articles » PMID: 22077561

Differential Expression of Canonical and Non-canonical Wnt Ligands in Ameloblastoma

Overview
Specialties Dentistry
Pathology
Date 2011 Nov 15
PMID 22077561
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Canonical and non-canonical Wnt signaling pathways modulate diverse cellular processes during embryogenesis and post-natally. Their deregulations have been implicated in cancer development and progression. Wnt signaling is essential for odontogenesis. The ameloblastoma is an odontogenic epithelial neoplasm of enamel organ origin. Altered expressions of Wnts-1, -2, -5a, and -10a are detected in this tumor. The activity of other Wnt members remains unclarified.

Materials And Methods: Canonical (Wnts-1, -2, -3, -8a, -8b, -10a, and -10b), non-canonical (Wnts-4, -5a, -5b, -6, 7a, -7b, and -11), and indeterminate groups (Wnts-2b and -9b) were examined immunohistochemically in 72 cases of ameloblastoma (19 unicystic [UA], 35 solid/multicystic [SMA], eight desmoplastic [DA], and 10 recurrent [RA]).

Results: Canonical Wnt proteins (except Wnt-10b) were heterogeneously expressed in ameloblastoma. Their distribution patterns were distinctive with some overlap. Protein localization was mainly membranous and/or cytoplasmic. Overexpression of Wnt-1 in most subsets (UA = 19/19; SMA = 35/35; DA = 5/8; RA = 7/10) (P < 0.05), Wnt-3 in granular cell variant (n = 3/3), and Wnt-8b in DA (n = 8/8) was key observations. Wnts-8a and -10a demonstrated enhanced expression in tumoral buddings and acanthomatous areas. Non-canonical and indeterminate Wnts were absent except for limited Wnt-7b immunoreactivity in UA (n = 1/19) and SMA (n = 1/35). Stromal components expressed variable Wnt positivity.

Conclusion: Differential expression of Wnt ligands in different ameloblastoma subtypes suggests that the canonical and non-canonical Wnt pathways are selectively activated or repressed depending on the tumor cell differentiation status. Canonical Wnt pathway is most likely the main transduction pathway while Wnt-1 might be the key signaling molecule involved in ameloblastoma tumorigenesis.

Citing Articles

Wnt signaling aberrant activation drives ameloblastoma invasion and recurrence: bioinformatics and in vitro insights.

Qian Y, Zhang H, Li J, Huang L, Qin Y, Zhang J BMC Oral Health. 2024; 24(1):1421.

PMID: 39574093 PMC: 11583395. DOI: 10.1186/s12903-024-05003-0.


[Molecular basis of ameloblastoma pathogenesis: A review].

Riofrio Chung G, Santos Tucto T, Quispe-Salcedo A Rev Cient Odontol (Lima). 2024; 12(3):e212.

PMID: 39444727 PMC: 11495173. DOI: 10.21142/2523-2754-1203-2024-212.


Title of the article: diagnostic markers for odontogenic tumors: an insight: a review.

Rastogi V, Chaurasia S, Maddheshiya N, Dhungel D Discov Oncol. 2024; 15(1):558.

PMID: 39404913 PMC: 11480304. DOI: 10.1007/s12672-024-01237-0.


Evaluation of Expression of WNT1 and PTCH Genes in Peripheral Blood of Patients with Odontogenic Cysts and Tumours of the Jaws by Quantitative RT-PCR: A Pilot Study.

Kalyanasundaram S, Kandasamy S, John R J Maxillofac Oral Surg. 2023; 22(4):1123-1129.

PMID: 38105830 PMC: 10719437. DOI: 10.1007/s12663-023-02014-2.


SDF-1 induces directional chemotaxis of BMSCs at the intervertebral fusion site and promotes osteogenic differentiation by regulating Wnt/β-catenin in the bone marrow chimera spinal intervertebral fusion mouse model.

Zhang Q, Liang N, He B, Wu S, Wen D, Tang X Turk J Biol. 2023; 47(1):14-28.

PMID: 37529111 PMC: 10387946. DOI: 10.55730/1300-0152.2638.